Predictors of Recurrences in Stage II-III Breast Cancer in Patients Receiving Neoadjuvant Systemic Therapy

被引：0
|
作者：
Dayyat, A. [1 ]
Mheid, S. [1 ]
Erjan, A. [1 ]
AlHammadi, A. [1 ]
Alnsoor, A. [1 ]
Abdelrahman, F. [1 ]
Al Masri, H. [1 ]
Al-Rashdan, A. [1 ]
机构：
[1] King Hussein Canc Ctr, Amman, Jordan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.620
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2003
引用
收藏
页码：E2 / E2
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant combination for stage II-III breast cancer
    Bagchi, Sanjit
    [J]. LANCET ONCOLOGY, 2007, 8 (07): : 579 - 579
  • [2] Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy
    Chien, A. Jo
    Chambers, Julia
    Mcauley, Fiona
    Kaplan, Tessa
    Letourneau, Joseph
    Hwang, Jimmy
    Kim, Mi-Ok
    Melisko, Michelle E.
    Rugo, Hope S.
    Esserman, Laura J.
    Rosen, Mitchell P.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (01) : 151 - 159
  • [3] A randomized phase II neoadjuvant trial in patients with stage II-III and inflammatory breast cancer
    Somlo, G.
    Paz, B.
    Shen, J.
    Garberoglio, C.
    Luu, T.
    Chung, C.
    Hurria, A.
    Frankel, P.
    Baker, N.
    Wilczynski, S.
    Arnold, K.
    Yeb, Y.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S231 - S231
  • [4] Pegylated liposomal doxorubicin as neoadjuvant therapy for stage II-III locally advanced breast cancer
    Yao, Jia
    Pan, Shaobo
    Fan, Xiao
    Jiang, Xue
    Yang, Yuhong
    Jin, Jing
    Liu, Yu
    [J]. JOURNAL OF CHEMOTHERAPY, 2020, 32 (04) : 202 - 207
  • [5] Neoadjuvant biweekly chemotherapy with liposomal doxorubicin and docetaxel in patients with stage II-III breast cancer
    Alvarez, I
    Modolell, A.
    Mayordomo, J., I
    Heras, L.
    Villadiego, K.
    Rolfo, C. D.
    Garcia-Bueno, J. M.
    Pica, P.
    Murillo, L.
    Morales, S.
    Valera, P.
    Florian, J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [6] Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
    Lin, Po-Han
    Wang, Ming-Yang
    Lo, Chiao
    Tsai, Li-Wei
    Yen, Tzu-Chun
    Huang, Thomas Yoyan
    Huang, Wei-Chih
    Yang, Karen
    Chen, Chih-Kai
    Fan, Sheng-Chih
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Sentinel Lymph Node Biopsy is Precise After Primary Systemic Therapy in Stage II-III Breast Cancer Patients
    Reitsamer, Roland
    Menzel, Christian
    Glueck, Sylvia
    Rettenbacher, Lukas
    Weismann, Christian
    Hutarew, Georg
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S286 - S290
  • [8] Neoadjuvant trastuzumab in a sequential nonanthracycline-based regimen for patients with stage II-III breast cancer
    Carillio, G.
    Aiello, R.
    Ali, M.
    Mazzola, A.
    Scandurra, G.
    Taibi, E.
    Chiarenza, M.
    Fallica, G.
    Caruso, F.
    Caruso, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Metformin with neoadjuvant chemotherapy in stage II-III breast cancer: A phase II clinical trial
    Azazy, H. A.
    Gado, N. M.
    Salem, D. A.
    El-Ghamry, W. R.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S323 - S324
  • [10] Postmastectomy Radiation Therapy Improved Locoregional Control in Patients With Clinical Stage II-III Breast Cancer After Neoadjuvant Chemotherapy
    Cao, L.
    Chen, J.
    Xu, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E40 - E41
12345